Research
Dr. Fairley’s research interest include nanoscience and nanotechnology, particularly
the intracellular trafficking of nanoparticles.
Publications
A Simple Microfluidic Platform for Long-Term Analysis and Continuous Dual-Imaging
Detection of T-Cell Secreted IFN-γ and IL-2 on Antibody-Based Biochip. Baganizi DR,
Leroy L, Laplatine L, Fairley SJ, Heidmann S, Menad S, Livache T, Marche PN, Roupioz
Y. Biosensors (Basel). 2015 Dec 4;5(4):750-67. doi: 10.3390/bios5040750.
Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers
primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate
nanovaccine. Fairley SJ, Singh SR, Yilma AN, Waffo AB, Subbarayan P, Dixit S, Taha
MA, Cambridge CD, Dennis VA. Int J Nanomedicine. 2013;8:2085-99. doi: 10.2147/IJN.S44155.
Epub 2013 May 30.
Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis
DNA vaccine encapsulated in chitosan nanoparticles. Cambridge CD, Singh SR, Waffo
AB, Fairley SJ, Dennis VA. Int J Nanomedicine. 2013;8:1759-71. doi: 10.2147/IJN.S42723.
Epub 2013 May 10.
The anti-inflammatory cytokine, interleukin-10, inhibits inflammatory mediators in
human epithelial cells and mouse macrophages exposed to live and UV-inactivated Chlamydia
trachomatis. Yilma AN, Singh SR, Fairley SJ, Taha MA, Dennis VA. Mediators Inflamm.
2012;2012:520174. doi: 10.1155/2012/520174. Epub 2012 Feb 19.
